<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PBZVCPE5</identifier><date>2022</date><creator>Rajčević, Uroš</creator><creator>Smole, Anže</creator><relation>documents/doc/P/URN_NBN_SI_doc-PBZVCPE5_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PBZVCPE5_001.txt</relation><format format_type="issue">4</format><format format_type="volume">59</format><format format_type="type">article</format><format format_type="extent">str. 173-184</format><identifier identifier_type="DOI">10.26873/SVR-1513-2022</identifier><identifier identifier_type="COBISSID_HOST">142663939</identifier><identifier identifier_type="ISSN">1580-4003</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PBZVCPE5</identifier><language>eng</language><publisher publisher_location="Ljubljana">Založba Univerze v Ljubljani</publisher><source>Slovenian veterinary research</source><rights>BY-SA</rights><subject language_type_id="slv">Cell- and Tissue-Based Therapy</subject><subject language_type_id="slv">Heterografts</subject><subject language_type_id="slv">Mice</subject><title>Preclinical mouse models in adoptive cell therapies of cancer</title></Record>